CNS

Emraclidine (BMS-986372)

Bristol Myers Squibb

Selective M4 muscarinic receptor positive allosteric modulator. Novel MoA. Phase 2 EMPOWER positive. Phase 3 ongoing.

Schizophrenia

Linked Studies

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Loading comments…

Also Known As

Development codes

BMS-986372

Other names

emraclidine